Loading clinical trials...
Loading clinical trials...
The Effects of a Glucagon Receptor Antagonist (GRA) on Non-Glucose Metabolic Pathways in Patients With Type 1 Diabetes (Pilot Study)
Conditions
Interventions
REMD-477
Locations
1
United States
UC San Diego Altman Clinical & Translational Research Institute
La Jolla, California, United States
Start Date
July 1, 2019
Primary Completion Date
July 31, 2021
Completion Date
May 31, 2022
Last Updated
July 15, 2022
NCT07224321
NCT06474598
NCT07051005
NCT02734277
NCT06575426
NCT07356089
Lead Sponsor
University of California, San Diego
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions